Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics
There is critical need for improved biomarker assessment platforms which integrate traditional pathological parameters (TNM stage, grade and ER/PR/HER2 status) with molecular profiling, to better define prognostic subgroups or systemic treatment response. One roadblock is the lack of semi-quantitati...
Main Authors: | Yolanda Madarnas, Sandip K. SenGupta, Bruce E. Elliott, Jeremy Squire, Leda H. Raptis, Ashish B. Rajput, Andrew G. Day, Waheed Sangrar, Sonal Varma, Jamaica D. Cass |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/4/3/725 |
Similar Items
-
Immunohistochemical Expression of p27<sup>Kip1</sup>, p57<sup>Kip2</sup>, Cyclin D1, Nestin, and Ki-67 in Ependymoma
by: Shahad Iqneibi, et al.
Published: (2022-02-01) -
The role of cyclin D1, BCL-2, p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium
by: Elçin Süren, et al.
Published: (2021-01-01) -
A Semi-quantitative analysis of immunohistochemical expression of p63, Ki-67, Cyclin-D1, and p16 in common oral potentially malignant disorders and oral squamous cell carcinoma
by: P Sharada, et al.
Published: (2018-01-01) -
Non-Small Cell Lung Carcinoma: Cyclin D1, bcl-2, p53, Ki-67 and Her-2 Proteins Expression in Resected Tumors
by: Svjetlana Radović, et al.
Published: (2007-08-01) -
Deletion of P58IPK, the cellular inhibitor of the protein kinases PKR and PERK, causes bone changes and joint degeneration in mice.
by: Sophie eGilbert, et al.
Published: (2014-10-01)